Form 4: Hologic Merger Completes, Diana De Walt Reports Ownership Change

Hologic, Inc. has completed its merger, with reporting person Diana De Walt no longer beneficially owning common stock following the transaction.

Summary

• This filing reports a change in beneficial ownership for Diana De Walt, SVP of Human Resources at Hologic, Inc.
• The change is a result of the completion of a merger between Hologic, Inc. and Hopper Parent Inc. (through its subsidiary Hopper Merger Sub Inc.).
• Effective April 7, 2026, each share of Hologic common stock was converted into $76.00 in cash and one contingent value right (CVR) potentially worth up to $3.00.
• Time-vesting restricted stock unit awards held by De Walt were also converted into the right to receive the merger consideration.
• Following the merger, De Walt no longer beneficially owns any shares of Hologic common stock directly or indirectly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on the completion of a pre-announced merger and the resulting change in beneficial ownership, rather than new financial performance or strategic shifts.

Positives

• The merger was completed, providing shareholders with cash and potential additional value through CVRs.
• The transaction offers a clear exit for shareholders at a specified price ($76.00 cash plus CVRs).

Negatives

• The reporting person, Diana De Walt, no longer holds any direct or indirect beneficial ownership of Hologic common stock.
• The contingent value right (CVR) introduces uncertainty regarding the final payout, as it is 'up to $3.00' and 'if payable'.

Risks

• The value of the contingent value right (CVR) is not guaranteed and depends on future events and conditions specified in the CVR agreement.
• The merger results in Hologic becoming a wholly owned subsidiary of Parent, indicating a change in corporate structure and potential strategic direction under new ownership.

Future Outlook

The future outlook for Hologic is now under the ownership of Parent, with the specific terms of the CVRs representing potential future payments to former shareholders.

Management Comments

• The merger agreement was entered into on October 21, 2025.
• The merger was completed on April 7, 2026, with Hologic surviving as a wholly owned subsidiary of Parent.
• Each share of Hologic common stock was converted into $76.00 cash and a CVR for up to $3.00.

Industry Context

StockSavvy.ai notes that the completion of this merger signifies consolidation within the medical technology sector, a trend driven by the pursuit of scale, innovation, and market share. The structure of the deal, including a cash component and a contingent value right, is a common strategy to bridge valuation gaps between buyers and sellers in such transactions.

Stakeholder Impact

• Shareholders: Receive $76.00 cash per share plus a CVR, representing a liquidity event.
• Employees: The filing does not detail specific impacts on employees, but changes in ownership can lead to shifts in corporate culture and benefits.
• Management: Diana De Walt's beneficial ownership of Hologic stock has ceased as a direct result of the merger.

Next Steps

• Shareholders will receive the merger consideration as per the agreement.
• The contingent value rights (CVRs) will be subject to their own terms and conditions for potential future payouts.

Key Dates

Keywords

Hologic Inc, HOLX, Merger, SEC Form 4, Beneficial Ownership, Diana De Walt, Restricted Stock Units, Contingent Value Right, Corporate Action